EPISODE · Mar 11, 2024 · 4 MIN
[The good, the bad, the ugly] Editor's Review week of March 4
from Off Script: A Pharma Manufacturing Podcast · host Pharma Manufacturing
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Boehringer Ingelheim to cap out-of-pocket inhaler prices The bad — Amylyx ALS drug falls short in phase 3 trial The ugly — FDA delays Eli Lilly Alzheimer's drug decision with last-minute AdComm
What this episode covers
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Boehringer Ingelheim to cap out-of-pocket inhaler pricesThe bad — Amylyx ALS drug falls short in phase 3 trialThe ugly — FDA delays Eli Lilly Alzheimer's drug decision with last-minute AdComm
NOW PLAYING
[The good, the bad, the ugly] Editor's Review week of March 4
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m